id paper:paper_01884409_v33_n4_p371_Sciutto
record_format dspace
spelling paper:paper_01884409_v33_n4_p371_Sciutto2023-06-08T15:19:46Z New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis Antigen delivery Cysticercosis Synthetic vaccine Taenia crassiceps Taenia solium Vaccination carrier protein vaccine bacteriophage central nervous system conference paper cost benefit analysis cost effectiveness analysis cysticercosis developing country disease severity disease transmission host parasite interaction human immunity immunogenicity infection prevention infection rate neurocysticercosis nonhuman personal hygiene pig farming sex difference swine Taenia solium transgenic plant vaccination Animals Base Sequence Cholera Toxin Cysticercosis Cysticercus Humans Molecular Sequence Data Plants, Genetically Modified Plasmids Recombinant Fusion Proteins Swine Swine Diseases Vaccination Vaccines, Subunit Cysticercosis caused by Taenia solium frequently affects human health and rustic porciculture. Cysticerci may localize in the central nervous system of humans causing neurocysticercosis, a major health problem in undeveloped countries. Prevalence and intensity of this disease in pigs and humans are related to social factors (poor personal hygiene, low sanitary conditions, rustic rearing of pigs, open fecalism) and possibly to biological factors such as immunity, genetic background, and gender. The indispensable role of pigs as an obligatory intermediate host in the life cycle offers the possibility of interfering with transmission through vaccination of pigs. An effective vaccine based on three synthetic peptides against pig cysticercosis has been successfully developed and proved effective in experimental and field conditions. The well-defined peptides that constitute the cysticercosis vaccine offer the possibility to explore alternative forms of antigen production and delivery systems that may improve the cost/benefit of this and other vaccines. Encouraging results were obtained in attempts to produce large amounts of these peptides and increased its immunogenicity by expression in recombinant filamentous phage (M13), in transgenic plants (carrots and papaya), and associated to bacterial immunogenic carrier proteins. © 2002 IMSS. Published by Elsevier Science Inc. 2002 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01884409_v33_n4_p371_Sciutto http://hdl.handle.net/20.500.12110/paper_01884409_v33_n4_p371_Sciutto
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antigen delivery
Cysticercosis
Synthetic vaccine
Taenia crassiceps
Taenia solium
Vaccination
carrier protein
vaccine
bacteriophage
central nervous system
conference paper
cost benefit analysis
cost effectiveness analysis
cysticercosis
developing country
disease severity
disease transmission
host parasite interaction
human
immunity
immunogenicity
infection prevention
infection rate
neurocysticercosis
nonhuman
personal hygiene
pig farming
sex difference
swine
Taenia solium
transgenic plant
vaccination
Animals
Base Sequence
Cholera Toxin
Cysticercosis
Cysticercus
Humans
Molecular Sequence Data
Plants, Genetically Modified
Plasmids
Recombinant Fusion Proteins
Swine
Swine Diseases
Vaccination
Vaccines, Subunit
spellingShingle Antigen delivery
Cysticercosis
Synthetic vaccine
Taenia crassiceps
Taenia solium
Vaccination
carrier protein
vaccine
bacteriophage
central nervous system
conference paper
cost benefit analysis
cost effectiveness analysis
cysticercosis
developing country
disease severity
disease transmission
host parasite interaction
human
immunity
immunogenicity
infection prevention
infection rate
neurocysticercosis
nonhuman
personal hygiene
pig farming
sex difference
swine
Taenia solium
transgenic plant
vaccination
Animals
Base Sequence
Cholera Toxin
Cysticercosis
Cysticercus
Humans
Molecular Sequence Data
Plants, Genetically Modified
Plasmids
Recombinant Fusion Proteins
Swine
Swine Diseases
Vaccination
Vaccines, Subunit
New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
topic_facet Antigen delivery
Cysticercosis
Synthetic vaccine
Taenia crassiceps
Taenia solium
Vaccination
carrier protein
vaccine
bacteriophage
central nervous system
conference paper
cost benefit analysis
cost effectiveness analysis
cysticercosis
developing country
disease severity
disease transmission
host parasite interaction
human
immunity
immunogenicity
infection prevention
infection rate
neurocysticercosis
nonhuman
personal hygiene
pig farming
sex difference
swine
Taenia solium
transgenic plant
vaccination
Animals
Base Sequence
Cholera Toxin
Cysticercosis
Cysticercus
Humans
Molecular Sequence Data
Plants, Genetically Modified
Plasmids
Recombinant Fusion Proteins
Swine
Swine Diseases
Vaccination
Vaccines, Subunit
description Cysticercosis caused by Taenia solium frequently affects human health and rustic porciculture. Cysticerci may localize in the central nervous system of humans causing neurocysticercosis, a major health problem in undeveloped countries. Prevalence and intensity of this disease in pigs and humans are related to social factors (poor personal hygiene, low sanitary conditions, rustic rearing of pigs, open fecalism) and possibly to biological factors such as immunity, genetic background, and gender. The indispensable role of pigs as an obligatory intermediate host in the life cycle offers the possibility of interfering with transmission through vaccination of pigs. An effective vaccine based on three synthetic peptides against pig cysticercosis has been successfully developed and proved effective in experimental and field conditions. The well-defined peptides that constitute the cysticercosis vaccine offer the possibility to explore alternative forms of antigen production and delivery systems that may improve the cost/benefit of this and other vaccines. Encouraging results were obtained in attempts to produce large amounts of these peptides and increased its immunogenicity by expression in recombinant filamentous phage (M13), in transgenic plants (carrots and papaya), and associated to bacterial immunogenic carrier proteins. © 2002 IMSS. Published by Elsevier Science Inc.
title New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
title_short New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
title_full New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
title_fullStr New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
title_full_unstemmed New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis
title_sort new approaches to improve a peptide vaccine against porcine taenia solium cysticercosis
publishDate 2002
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01884409_v33_n4_p371_Sciutto
http://hdl.handle.net/20.500.12110/paper_01884409_v33_n4_p371_Sciutto
_version_ 1768545644016828416